{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:30:26Z","timestamp":1794000626257,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"International scientific and technological innovation cooperation between governments from Ministry of Science and Technology of the People's Republic of China","award":["2021YFE0108200"],"award-info":[{"award-number":["2021YFE0108200"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC32311530061"],"award-info":[{"award-number":["NSFC32311530061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100709"],"award-info":[{"award-number":["32100709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371784"],"award-info":[{"award-number":["82371784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2507900"],"award-info":[{"award-number":["2023YFC2507900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2706300"],"award-info":[{"award-number":["2023YFC2706300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mutations in the signal transducer and activator of transcription 3 (\n                    <jats:italic>STAT3<\/jats:italic>\n                    ) gene are strongly associated with Hyper-IgE Syndrome (HIES), a rare immunodeficiency disorder characterized by elevated levels of IgE and recurrent infections. The molecular mechanisms of how STAT3 dysfunction contributes to the pathophysiology of HIES are complex and not fully elucidated, especially in natural killer (NK) cells, which are crucial for the immune response against infections and malignancies. Employing single-cell sequencing and flow cytometry, we investigated the effects of\n                    <jats:italic>STAT3<\/jats:italic>\n                    mutations on immune cell development, differentiation, and function. Our findings revealed an increased population of CX3CR1\n                    <jats:sup>+<\/jats:sup>\n                    CD57\n                    <jats:sup>+<\/jats:sup>\n                    NK and NKT cells, suggesting their terminal differentiation and functional exhaustion. The trend of Th2 cell differentiation was identified in patients with\n                    <jats:italic>STAT3<\/jats:italic>\n                    mutations and in STAT3 conditional knockout (CKO) mice. CUT&amp;Tag analysis on CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells from carriers of the\n                    <jats:italic>STAT3<\/jats:italic>\n                    intron22 (2144\u2009+\u20091G\u2009&gt;\u2009A) mutation revealed enhanced binding of the variant STAT3 to the transcription start site of\n                    <jats:italic>IL-4<\/jats:italic>\n                    , which provides an explanation for the elevated peripheral IgE levels observed in these\n                    <jats:italic>STAT3<\/jats:italic>\n                    mutation patients. This study enhances our understanding of how\n                    <jats:italic>STAT3<\/jats:italic>\n                    mutations drive immunological dysregulation in HIES. The identified changes in immunological signature and transcriptional mechanisms offer new insights into therapeutic targets for HIES.\n                  <\/jats:p>","DOI":"10.1186\/s43556-025-00323-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T09:04:11Z","timestamp":1762765451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["STAT3 regulates NK and NKT cell differentiation through C-X3-C motif chemokine receptor\u00a01\u00a0 (CX3CR1) in hyper-IgE syndrome"],"prefix":"10.1186","volume":"6","author":[{"given":"Ju","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bitzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7028-4625","authenticated-orcid":false,"given":"Chaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"5155","key":"323_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.8140422","volume":"264","author":"Z Zhong","year":"1994","unstructured":"Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264(5155):95\u20138. https:\/\/doi.org\/10.1126\/science.8140422.","journal-title":"Science"},{"key":"323_CR2","doi-asserted-by":"publisher","unstructured":"Goel S, Sahu S, Minz R W, Singh S, Suri D, Oh Y M, et al. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome. Front Immunol. 2018;91080. https:\/\/doi.org\/10.3389\/fimmu.2018.01080.","DOI":"10.3389\/fimmu.2018.01080"},{"issue":"4","key":"323_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"323_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pccm.2025.05.001","volume":"3","author":"S Thawanaphong","year":"2025","unstructured":"Thawanaphong S, Nolasco S, Nair P. Achieving remission in severe asthma. Chin Med J Pulm Crit Care Med. 2025;3(2):77\u201387. https:\/\/doi.org\/10.1016\/j.pccm.2025.05.001.","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"323_CR5","doi-asserted-by":"publisher","unstructured":"B\u00e9ziat V, Li J, Lin J X, Ma C S, Li P, Bousfiha A, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018; 3(24). https:\/\/doi.org\/10.1126\/sciimmunol.aat4956.","DOI":"10.1126\/sciimmunol.aat4956"},{"issue":"6","key":"323_CR6","doi-asserted-by":"publisher","first-page":"189207","DOI":"10.1016\/j.bbcan.2024.189207","volume":"1879","author":"D Shi","year":"2024","unstructured":"Shi D, Tao J, Man S, Zhang N, Ma L, Guo L, et al. Structure, function, signaling pathways and clinical therapeutics: the translational potential of STAT3 as a target for cancer therapy. Biochimica et Biophysica Acta (BBA). 2024;1879(6):189207. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189207.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"323_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jmb.2016.01.003","volume":"428","author":"AT Namanja","year":"2016","unstructured":"Namanja AT, Wang J, Buettner R, Colson L, Chen Y. Allosteric communication across STAT3 domains associated with STAT3 function and disease-causing mutation. J Mol Biol. 2016;428(3):579\u201389. https:\/\/doi.org\/10.1016\/j.jmb.2016.01.003.","journal-title":"J Mol Biol"},{"issue":"1","key":"323_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8(1):204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7.","journal-title":"Signal Transduct Target Ther"},{"key":"323_CR9","doi-asserted-by":"publisher","unstructured":"Frede N, Rojas-Restrepo J, Caballero Garcia De Oteyza A, Buchta M, H\u00fcbscher K, G\u00e1mez-D\u00edaz L, et al. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE syndromes and\/or chronic mucocutaneous candidiasis. J Clin Immunol. 2021; 41(8):1804\u20131838. https:\/\/doi.org\/10.1007\/s10875-021-01086-4.","DOI":"10.1007\/s10875-021-01086-4"},{"key":"323_CR10","doi-asserted-by":"publisher","unstructured":"Hanlon M M, Rakovich T, Cunningham C C, Ansboro S, Veale D J, Fearon U, et al. STAT3 mediates the differential effects of oncostatin M and TNF\u03b1 on RA synovial fibroblast and endothelial cell function. Front Immunol. 2019; 102056. https:\/\/doi.org\/10.3389\/fimmu.2019.02056.","DOI":"10.3389\/fimmu.2019.02056"},{"key":"323_CR11","doi-asserted-by":"publisher","unstructured":"Asano T, Khourieh J, Zhang P, Rapaport F, Spaan A N, Li J, et al. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance. J Exp Med. 2021;218(8). https:\/\/doi.org\/10.1084\/jem.20202592.","DOI":"10.1084\/jem.20202592"},{"key":"323_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","volume":"203","author":"B Grimbacher","year":"2005","unstructured":"Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev. 2005;203:244\u201350. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00228.x.","journal-title":"Immunol Rev"},{"issue":"8","key":"323_CR13","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1002\/mco2.662","volume":"5","author":"JC Liu","year":"2024","unstructured":"Liu JC, Zhang K, Zhang X, Guan F, Zeng H, Kubo M, et al. Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases. MedComm (2020). 2024;5(8):e662. https:\/\/doi.org\/10.1002\/mco2.662.","journal-title":"MedComm (2020)"},{"issue":"6","key":"323_CR14","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1084\/jem.143.6.1382","volume":"143","author":"J Jandinski","year":"1976","unstructured":"Jandinski J, Cantor H, Tadakuma T, Peavy DL, Pierce CW. Separation of helper T cells from suppressor T cells expressing different Ly components. I. Polyclonal activation: suppressor and helper activities are inherent properties of distinct T-cell subclasses. J Exp Med. 1976;143(6):1382\u201390. https:\/\/doi.org\/10.1084\/jem.143.6.1382.","journal-title":"J Exp Med"},{"key":"323_CR15","doi-asserted-by":"publisher","unstructured":"Dong C. Cytokine regulation and function in T cells. Annu Rev Immunol. 2021;3951\u201376. https:\/\/doi.org\/10.1146\/annurev-immunol-061020-053702.","DOI":"10.1146\/annurev-immunol-061020-053702"},{"key":"323_CR16","doi-asserted-by":"publisher","unstructured":"Coffman R L, Seymour B W, Lebman D A, Hiraki D D, Christiansen J A, Shrader B, et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev. 1988;1025\u201328. https:\/\/doi.org\/10.1111\/j.1600-065x.1988.tb00739.x.","DOI":"10.1111\/j.1600-065x.1988.tb00739.x"},{"key":"323_CR17","doi-asserted-by":"publisher","unstructured":"Wang Y, Chen X, Zhou L, Chinn E, Yue J. The mechanism underlying the inverse proportion between serum IgE concentration and Stat3 transcriptional activity depends on Stat3 mutation type. Int Immunopharm. 2023;124111031. https:\/\/doi.org\/10.1016\/j.intimp.2023.111031.","DOI":"10.1016\/j.intimp.2023.111031"},{"issue":"11","key":"323_CR18","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.4049\/jimmunol.1203401","volume":"190","author":"A Poli","year":"2013","unstructured":"Poli A, Kmiecik J, Domingues O, Hentges F, Bl\u00e9ry M, Chekenya M, et al. NK cells in central nervous system disorders. J Immunol. 2013;190(11):5355\u201362. https:\/\/doi.org\/10.4049\/jimmunol.1203401.","journal-title":"J Immunol"},{"issue":"3","key":"323_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/cea.12022","volume":"43","author":"AE El-Shazly","year":"2013","unstructured":"El-Shazly AE, Doloriert HC, Bisig B, Lefebvre PP, Delvenne P, Jacobs N. Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue. Clin Exp Allergy. 2013;43(3):322\u201331. https:\/\/doi.org\/10.1111\/cea.12022.","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"323_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2249.2005.02777.x","volume":"140","author":"E Aktas","year":"2005","unstructured":"Aktas E, Akdis M, Bilgic S, Disch R, Falk CS, Blaser K, et al. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol. 2005;140(2):301\u20139. https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02777.x.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"323_CR21","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1111\/cas.16359","volume":"115","author":"J Ma","year":"2024","unstructured":"Ma J, Wu Y, Wu S, Fang Z, Chen L, Jiang J, et al. CX3CR1(+)CD8(+) T cells: key players in antitumor immunity. Cancer Sci. 2024;115(12):3838\u201345. https:\/\/doi.org\/10.1111\/cas.16359.","journal-title":"Cancer Sci"},{"issue":"7","key":"323_CR22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24(7):978\u201385. https:\/\/doi.org\/10.1038\/s41591-018-0045-3.","journal-title":"Nat Med"},{"issue":"1","key":"323_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2567.2011.03409.x","volume":"133","author":"I Hamann","year":"2011","unstructured":"Hamann I, Unterwalder N, Cardona AE, Meisel C, Zipp F, Ransohoff RM, et al. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology. 2011;133(1):62\u201373. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03409.x.","journal-title":"Immunology"},{"issue":"2","key":"323_CR24","first-page":"485","volume":"15","author":"X Zhang","year":"2006","unstructured":"Zhang X, Wei H, Wang H, Tian Z. Involvement of interaction between fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells. Oncol Rep. 2006;15(2):485\u20138.","journal-title":"Oncol Rep"},{"issue":"10","key":"323_CR25","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1182\/blood-2016-08-732164","volume":"129","author":"P Hamon","year":"2017","unstructured":"Hamon P, Loyher PL, Baudesson De Chanville C, Licata F, Combadi\u00e8re C, Boissonnas A. CX3CR1-dependent endothelial margination modulates Ly6C(high) monocyte systemic deployment upon inflammation in mice. Blood. 2017;129(10):1296\u2013307. https:\/\/doi.org\/10.1182\/blood-2016-08-732164.","journal-title":"Blood"},{"issue":"17","key":"323_CR26","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1182\/blood-2010-07-297101","volume":"117","author":"G Scium\u00e8","year":"2011","unstructured":"Scium\u00e8 G, De Angelis G, Benigni G, Ponzetta A, Morrone S, Santoni A, et al. CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. Blood. 2011;117(17):4467\u201375. https:\/\/doi.org\/10.1182\/blood-2010-07-297101.","journal-title":"Blood"},{"issue":"4","key":"323_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","volume":"180","author":"P Dogra","year":"2020","unstructured":"Dogra P, Rancan C, Ma W, Toth M, Senda T, Carpenter DJ, et al. Tissue determinants of human NK cell development, function, and residence. Cell. 2020;180(4):749-763.e713. https:\/\/doi.org\/10.1016\/j.cell.2020.01.022.","journal-title":"Cell"},{"issue":"20","key":"323_CR28","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1182\/blood-2011-04-347526","volume":"118","author":"TD Kim","year":"2011","unstructured":"Kim TD, Lee SU, Yun S, Sun HN, Lee SH, Kim JW, et al. Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. Blood. 2011;118(20):5476\u201386. https:\/\/doi.org\/10.1182\/blood-2011-04-347526.","journal-title":"Blood"},{"issue":"2","key":"323_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00018-019-03277-0","volume":"77","author":"D Fang","year":"2020","unstructured":"Fang D, Zhu J. Molecular switches for regulating the differentiation of inflammatory and IL-10-producing anti-inflammatory T-helper cells. Cell Mol Life Sci. 2020;77(2):289\u2013303. https:\/\/doi.org\/10.1007\/s00018-019-03277-0.","journal-title":"Cell Mol Life Sci"},{"issue":"D1","key":"323_CR30","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022;50(D1):D165-d173. https:\/\/doi.org\/10.1093\/nar\/gkab1113.","journal-title":"Nucleic Acids Res"},{"key":"323_CR31","doi-asserted-by":"publisher","unstructured":"Sun Q, Zhao X, Li R, Liu D, Pan B, Xie B, et al. STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection. J Exp Med. 2023;220(4). https:\/\/doi.org\/10.1084\/jem.20220686.","DOI":"10.1084\/jem.20220686"},{"issue":"3","key":"323_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2009.08.014","volume":"31","author":"NA Barrett","year":"2009","unstructured":"Barrett NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity. 2009;31(3):425\u201337. https:\/\/doi.org\/10.1016\/j.immuni.2009.08.014.","journal-title":"Immunity"},{"issue":"13","key":"323_CR33","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/cvr\/cvab285","volume":"117","author":"F Porsch","year":"2021","unstructured":"Porsch F, Mallat Z, Binder CJ. Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. Cardiovasc Res. 2021;117(13):2544\u201362. https:\/\/doi.org\/10.1093\/cvr\/cvab285.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"323_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Sch\u00e4ffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424-432.e428. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.059.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"323_CR35","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.4049\/jimmunol.1401821","volume":"193","author":"DM Strauss-Albee","year":"2014","unstructured":"Strauss-Albee DM, Horowitz A, Parham P, Blish CA. Coordinated regulation of NK receptor expression in the maturing human immune system. J Immunol. 2014;193(10):4871\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1401821.","journal-title":"J Immunol"},{"issue":"4","key":"323_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","volume":"65","author":"H Kared","year":"2016","unstructured":"Kared H, Martelli S, Ng TP, Pender SL, Larbi A. CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol Immunother. 2016;65(4):441\u201352. https:\/\/doi.org\/10.1007\/s00262-016-1803-z.","journal-title":"Cancer Immunol Immunother"},{"issue":"16","key":"323_CR37","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","volume":"119","author":"LC Ndhlovu","year":"2012","unstructured":"Ndhlovu LC, Lopez-Verg\u00e8s S, Barbour JD, Jones RB, Jha AR, Long BR, et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood. 2012;119(16):3734\u201343. https:\/\/doi.org\/10.1182\/blood-2011-11-392951.","journal-title":"Blood"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00323-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00323-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00323-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:16:18Z","timestamp":1762881378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00323-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00323-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Three patients with\n                      STAT3\n                      gene mutations and nine age- and sex-matched healthy controls were enrolled in the study from Tongji Hospital and Wuhan Children\u2019s Hospital. The parents of all participants provided written informed consent, approved by the ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Ethical approval number: 2025-S108). The animals used in our experiments were approved by the Animal Ethics Committee of Huazhong University of Science and Technology, approval number is 4783.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no relevant conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}